Search Results - "Rava, Andrew"

Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States by Moon, Helen H, Kearney, Mairead, Mahmoudpour, Seyed Hamidreza, Ike, Chiemeka, Morris, Valerie, Rava, Andrew, Kim, Sonia, Sun, Haiyan, Boyd, Marley, Gomez Rey, Gabriel

“…For patients with locally advanced/metastatic urothelial carcinoma (la/mUC), first-line (1L) treatment with platinum-based chemotherapy (PBC) followed by…”
Get full text

Estimating prevalence of classical homocystinuria in the United States using Optum's de-identified market clarity data by Jain, Mahim, Shah, Mehul, Thakker, Kamlesh M., Rava, Andrew, Block, Agness Pelts, Ndiba-Markey, Colette, Pinto, Lionel

“…Prevalence estimates for classical homocystinuria (HCU) are variable and likely underestimated due to underdiagnosis. Claims data represent a strong but seldom…”
Get full text

Clinicopathological Characteristics of Adult IgA Nephropathy in the United States by Caster, Dawn J., Abner, Clint W., Walker, Patrick D., Wang, Kaijun, Heo, Jihaeng, Rava, Andrew R., Bunke, Martin

“…IgA nephropathy (IgAN) is a progressive autoimmune kidney disease and a leading cause of glomerular disease that can result in kidney failure (KF). The median…”
Get full text

Corrigendum to "Clinicopathological Characteristics of Adult IgA Nephropathy in the United States" [ Kidney International Reports Volume 8, Issue 9, September 2023, Pages 1792-1800] by Caster, Dawn J, Abner, Clint W, Walker, Patrick D, Wang, Kaijun, Heo, Jihaeng, Rava, Andrew R, Bunke, Martin

“…[This corrects the article DOI: 10.1016/j.ekir.2023.06.016.]…”
Get full text

Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey by Nazareth, Tara A., Rava, Andrew R., Polyakov, Jackie L., Banfe, Edward N., Waltrip II, Royce W., Zerkowski, Kristine B., Herbert, Leslie B.

“…•Online survey of 5,300 MS patients, 50% moderately and 14% severely disabled.•1 in 5 reported > 2 relapses a year and 2/3 with serious relapse symptoms.•Those…”
Get full text

Real-world analysis of the underdiagnosis, clinical outcomes and associated burden of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in the United States by Wang, Yan, Rava, Andrew, Smurzynski, Marlene, Shah, Bonny, Thanataveerat, Anusorn, Al-Dakkak, Imad, Ong, Moh-Lim, Dvorak, Christopher C., Ho, Vincent T.

“…BackgroundThrombotic microangiopathy (TMA) associated with hematopoietic stem cell transplantation (HSCT-TMA) is a serious post-transplant complication…”
Get full text

Clinical Characteristics and Histopathology in Adults With Focal Segmental Glomerulosclerosis by Tuttle, Katherine R., Abner, Clint W., Walker, Patrick D., Wang, Kaijun, Rava, Andrew, Heo, Jihaeng, Bunke, Martin

“…Few data are available regarding histological features at the time of focal segmental glomerulosclerosis (FSGS) diagnosis among diverse real-world populations…”
Get full text

Cardiovascular, Kidney Failure, and All-Cause Mortality Events in Patients with FSGS in a US Real-World Database by Velez, Juan Carlos Q, Thakker, Kamlesh M, Bensink, Mark E, Lerma, Edgar V, Lieblich, Richard, Bunke, C Martin, Gong, Wu, Wang, Kaijun, Rava, Andrew R, Amari, Diana T, Oliveri, David, Murphy, Michael V, Cork, David M W

Get full text

Kidney Failure Events, Cardiovascular Disease Events, and All-Cause Mortality in Patients with IgA Nephropathy in a Real-World Database by Lerma, Edgar V, Thakker, Kamlesh M, Bensink, Mark E, Lieblich, Richard, Bunke, C Martin, Gong, Wu, Rava, Andrew R, Wang, Kaijun, Amari, Diana T, Oliveri, David, Murphy, Michael V, Cork, David M W, Velez, Juan Carlos Q

Get full text

Impact of Proteinuria and Kidney Function Decline on Health Care Costs and Resource Utilization in Adults With IgA Nephropathy in the United States: A Retrospective Analysis by Lerma, Edgar V., Bensink, Mark E., Thakker, Kamlesh M., Lieblich, Richard, Bunke, Martin, Rava, Andrew, Wang, Kaijun, Murphy, Michael V., Oliveri, David, Amari, Diana T., Cork, David M.W., Velez, Juan Carlos Q.

“…Among patients with IgA nephropathy (IgAN), proteinuria and decline in kidney function may be associated with increased economic burden. This study aimed to…”
Get full text

Retrospective analysis of adherence and persistence of encorafenib in combination with cetuximab among patients with BRAF metastatic CRC in the United States (US) by Parikh, Aparna Raj, Vieira, Maria Cecilia, Silver, Michelle, Rava, Andrew, Rau, Reina, Li, Benjamin

“…64 Background: The BRAF V600E mutation (BRAF-m) occurs in approximately 7% of patients with metastatic CRC (mCRC). Encorafenib (enco) in combination with…”
Get full text

Retrospective analysis of the real-world demographics, clinical characteristics, and treatment patterns in metastatic CRC among patients treated with encorafenib in combination with cetuximab in the United States by Parikh, Aparna Raj, Vieira, Maria Cecilia, Silver, Michelle, Rava, Andrew, Rau, Reina, Li, Benjamin

“…63 Background: The presence of BRAF V600E mutations (BRAF-m) occurs in approximately 7% of patients with metastatic CRC (mCRC). Encorafenib (enco) plus…”
Get full text

Retrospective Cohort Study to Quantify the Economic Impact of Mild Cognitive Impairment (P7-6.002) by Frech, Feride, Li, Gang, Ding, Yingjie, Ndiba-Markey, Colette, Rava, Andrew, Batrla, Richard, Hampel, Harald

“…Abstract only…”
Get full text

Persistence, Health Care Resource Utilization, and Costs Among OnabotulinumtoxinA-Treated Patients With Cervical Dystonia in the US by Dashtipour, Khashayar, Sadeghi, Marjan, Heath, Maria, Rava, Andrew, Liu, Jinjie, Sun, Haiyan, Dong, Yanan, Lee, Jae

Get full text

Economic burden of classical homocystinuria in the United States by Jain, Mahim, Pinto, Lionel, Shah, Mehul, Rava, Andrew, Ndiba-Markey, Colette, Amari, Diana

Get full text

Impact of Ibrutinib Dose Reduction on Duration of Therapy in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma by Shadman, Mazyar, Karve, Sudeep, Patel, Sima, Rava, Andrew, Sun, Haiyan, Howarth, Amanda, Tomicki, Samantha, Srivastava, Bhavini P., Stephens, Deborah M.

“…Background: Ibrutinib (Ibr) has demonstrated a significant progression-free survival and overall survival benefit compared to chemotherapy in multiple phase 3…”
Get full text

Treatment Regimens and Clinical Outcomes Among Follicular Lymphoma Patients Treated with Third-Line Therapy in the United States: A Real-World EHR Study by Dai, Dong, Heo, Ji Haeng, Rava, Andrew, Jousseaume, Etienne, Ramos, Roberto, Bollu, Vamsi

“…Objective: To determine treatment regimens used in clinical practice and the associated clinical outcomes among third line (3L) follicular lymphoma (FL)…”
Get full text

DEVELOPMENT OF A PATIENT IDENTIFICATION ALGORITHM TO ESTIMATE PREVALENCE OF CLASSICAL HOMOCYSTINURIA IN THE UNITED STATES (US) by Jain, Mahim, Pinto, Lionel, Thakker, Kamlesh, Shah, Mehul, Rava, Andrew, Ndiba-Markey, Colette, Cork, David

Get full text

1692-P: Prevalence, Characteristics, and Clinical Burden among Patients with Overweight or Obesity and Established ASCVD in a U.S. Real-World Setting by Michalak, Wojciech, Boame, Nana, Zhao, Xin, Lamarre, Neil, Rava, Andrew, Doan, Quan V, Faurby, Mads, Hartaigh, Briain O, Fabricatore, Anthony, Zhao, Zhenxiang

“…This study aimed to estimate the prevalence of overweight or obesity (Ov/Ob; BMI ≥ 25.0 kg/m2) in individuals with established ASCVD (eASCVD; included MI,…”
Get full text

Evaluating the Predictors of Structural Features in Kidney Biopsies From Adults With Focal Segmental Glomerulosclerosis: TH-PO478 by Tuttle, Katherine R., Abner, Clint, Walker, Patrick D., Wang, Kaijun, Bunke, Martin C., Heo, Ji Haeng, Rava, Andrew

Get full text